GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-08-17		NCT07209813

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Gene Key Life Technology Co., Ltd	5

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
302 Hospital	Beijing	China	1
Jiangxi Cancer Hospital	Nanchang	China	48
Nanjing Second Hospital	Nanjing	China	2
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125
The Second Xiangya Hospital of Central South University	Changsha	China	67
Zhejiang Cancer Hospital	Hangzhou	China	164
Zhongda Hospital	Nanjing	China	7